CELIAC DISEASE ANTIBODY SELF-TEST - ANVISA Registration 80535240072

Access comprehensive regulatory information for CELIAC DISEASE ANTIBODY SELF-TEST in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80535240072 and manufactured by CHEMBIO DIAGNOSTICS BRAZIL LTDA.. The registration is held by CHEMBIO DIAGNOSTICS BRAZIL LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including VEDALAB, BIOSYNEX SA, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.